IRIS UniCatt

Fianchi, Luana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.181
EU - Europa 5.732
AS - Asia 4.543
SA - Sud America 885
Continente sconosciuto - Info sul continente non disponibili 198
AF - Africa 119
OC - Oceania 21
Totale 18.679
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.998
DE - Germania 2.191
SG - Singapore 1.940
CN - Cina 1.295
SE - Svezia 799
BR - Brasile 716
IT - Italia 468
FR - Francia 387
NL - Olanda 382
UA - Ucraina 370
VN - Vietnam 354
PL - Polonia 281
GB - Regno Unito 227
IN - India 199
IE - Irlanda 198
ID - Indonesia 131
FI - Finlandia 128
RU - Federazione Russa 118
JP - Giappone 100
HK - Hong Kong 91
BD - Bangladesh 88
CA - Canada 73
IQ - Iraq 64
MX - Messico 61
TR - Turchia 60
AR - Argentina 56
ZA - Sudafrica 35
ES - Italia 32
KR - Corea 30
PK - Pakistan 27
CO - Colombia 26
SA - Arabia Saudita 26
EC - Ecuador 24
BE - Belgio 22
AT - Austria 20
CL - Cile 19
AU - Australia 18
NO - Norvegia 18
JO - Giordania 17
CI - Costa d'Avorio 16
LT - Lituania 15
EG - Egitto 14
RO - Romania 14
UZ - Uzbekistan 14
KE - Kenya 12
PH - Filippine 12
VE - Venezuela 12
MA - Marocco 11
CZ - Repubblica Ceca 10
IR - Iran 10
KZ - Kazakistan 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
GR - Grecia 8
MY - Malesia 8
NP - Nepal 8
AZ - Azerbaigian 7
IL - Israele 7
JM - Giamaica 7
PY - Paraguay 7
BG - Bulgaria 6
BO - Bolivia 6
HU - Ungheria 6
LV - Lettonia 6
TH - Thailandia 6
TN - Tunisia 6
UY - Uruguay 6
AL - Albania 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
ET - Etiopia 5
KG - Kirghizistan 5
PS - Palestinian Territory 5
OM - Oman 4
PA - Panama 4
PR - Porto Rico 4
TT - Trinidad e Tobago 4
AO - Angola 3
BH - Bahrain 3
BZ - Belize 3
CH - Svizzera 3
GE - Georgia 3
HN - Honduras 3
HR - Croazia 3
NI - Nicaragua 3
BB - Barbados 2
BW - Botswana 2
EU - Europa 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
LY - Libia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
Totale 18.458
Salva come PNG Salva come JPEG
Città #
Singapore 1.030
Chandler 789
Ashburn 700
San Jose 625
Amsterdam 355
Warsaw 266
Jacksonville 261
Beijing 242
Los Angeles 219
Frankfurt am Main 186
Dublin 185
San Mateo 181
New York 175
Ann Arbor 172
Dearborn 154
Nanjing 153
Wilmington 145
Houston 134
Lauterbourg 120
Nürnberg 120
Chicago 119
Jakarta 118
Ho Chi Minh City 116
Hefei 113
Woodbridge 109
Milan 107
Munich 97
Hanoi 94
Boston 88
Hong Kong 85
Fairfield 81
São Paulo 77
Tokyo 77
Bremen 74
Buffalo 72
Moscow 72
Seattle 68
Lawrence 67
Cattolica 66
St Louis 59
Rome 56
Nanchang 54
Dallas 51
Redwood City 50
Hyderabad 46
Redmond 46
Shanghai 46
Zhengzhou 46
Santa Clara 45
Marseille 43
Council Bluffs 41
The Dalles 41
Hangzhou 38
Kunming 37
Shenyang 37
Lancaster 35
Princeton 35
Tianjin 33
Atlanta 32
Kent 31
Leawood 30
London 30
Cambridge 29
Brooklyn 28
Boardman 27
Da Nang 27
Izmir 27
Salt Lake City 26
Auburn Hills 25
Hebei 25
Baghdad 24
Guangzhou 24
Jiaxing 24
Rio de Janeiro 24
Seoul 23
Brussels 22
Memphis 22
Mexico City 22
Montreal 22
Orem 22
Philadelphia 22
Mountain View 21
Nuremberg 21
Paris 21
Augusta 19
Helsinki 19
Pune 19
San Francisco 19
Falls Church 18
Norwalk 18
University Park 18
Denver 17
Düsseldorf 17
Lappeenranta 17
Poplar 17
Tampa 17
Abidjan 16
Changsha 16
Chatsworth 16
Haiphong 16
Totale 9.681
Salva come PNG Salva come JPEG
Nome #
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 637
Factors associated with mortality in bacteremic patients with haematologic malignancies 528
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 437
Incidence of acute myeloid leukemia after breast cancer 386
Factors associated with mortality in bacteremic patients with hematologic malignancies. 379
Fanconi anemia gene variants in therapy-related myeloid neoplasms 331
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 305
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 271
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 245
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 244
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 243
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 232
Factors associated with mortality in bacteremic patients with hematologic malignancies. 220
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 220
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 215
Why methylation is not a marker predictive of response to hypomethylating agents 203
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 202
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 198
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 197
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 194
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 193
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 193
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 188
Epigenetic changes in therapy-related MDS/AML 187
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 187
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 184
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 178
Clonal evolution in therapy-related neoplasms 178
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 177
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 174
Similarities and differences between therapy-related and elderly acute myeloid leukemia 172
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 170
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 170
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 168
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 167
Primary plasma cell leukemia followed by testicular plasmacytoma 166
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 162
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 161
Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency 156
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 154
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 152
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 151
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 150
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 149
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 149
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 148
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 148
Small lymphocytic lymphoma in a patient with Fabry disease 144
Outcome of therapy-related myeloid neoplasms treated with azacitidine 142
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 142
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study 141
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 140
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 140
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 138
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 137
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 136
Small lymphocytic lymphoma in a patient with Fabry disease 135
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 133
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 132
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) 131
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 131
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 129
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 129
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up: The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry 128
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? 126
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 125
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 125
The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients. 122
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 122
Therapy-related myeloid neoplasms: Clinical perspectives 121
Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine 119
Disseminated geosmithia argillacea infection in a patient with ph-positive acute lymphoblastic leukemia. Case report and literature review 119
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 118
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 116
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in “Real-Life”: The SEIFEM Experience 115
Fungal pneumonia due to molds in patients with hematological malignancies. 115
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry 114
Current therapeutic approaches to fungal infections in immunocompromised hematological patients 114
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry 114
CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis 113
Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study 113
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 112
Polymorphisms within the ARNT2 and CX3CR1 Genes Are Associated with the Risk of Developing Invasive Aspergillosis 112
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 111
Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality? 108
High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study 107
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 107
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 106
The role of neutrophils in the development and outcome of zygomycosis in haematological patients 105
Rapid response of nodular CD30-positive mycosis fungoides to brentuximab vedotin 104
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry 103
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review 103
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 101
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study) 101
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study 100
Therapy-related myeloid neoplasms 100
Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia 100
Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome 99
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study 98
Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality? 98
Totale 16.713
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.468
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022907 0 70 12 43 74 49 26 158 53 85 139 198
2022/20232.111 266 296 181 373 150 250 78 180 227 17 71 22
2023/2024961 49 270 32 31 29 192 53 22 12 26 125 120
2024/20252.386 58 73 159 47 208 57 107 99 351 216 673 338
2025/20266.218 844 178 339 602 920 821 906 302 485 464 222 135
2026/2027619 262 357 0 0 0 0 0 0 0 0 0 0
Totale 18.679